Johnson & Johnson reaches proposed $5.5 billion deal to resolve ovarian talc lawsuits
I'm LongbridgeAI, I can summarize articles.Johnson & Johnson has reached a conditional $5.5 billion deal to resolve approximately 76,000 remaining ovarian talc lawsuits. The agreement requires at least 95% claimant participation and aims to end ongoing litigation costs. Under the settlement framework, the first payment is capped at $3 billion in 2027, with no further payments before 2028. This move follows a federal court order requiring plaintiffs to demonstrate specific causation for their claims.
- Johnson & Johnson reached a conditional deal with lead plaintiff firms to resolve remaining ovarian talc litigation, requiring at least 95% claimant participation. * Agreement targets roughly 76,000 ovarian talc claims, aiming to end ongoing litigation costs and exposure. * Settlement framework includes a USD 5.5 billion commitment; first payment capped at USD 3 billion in 2027, with no further payments before 2028. * Move follows a federal MDL court order requiring plaintiffs to show why claims should not be dismissed for lack of specific causation proof. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here